Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 248.85 million compared to CNY 235.39 million a year ago. Revenue was CNY 248.85 million compared to CNY 235.39 million a year ago. Net income was CNY 51.82 million compared to CNY 45.73 million a year ago. Basic earnings per share from continuing operations was CNY 0.103 compared to CNY 0.0909 a year ago. Diluted earnings per share from continuing operations was CNY 0.103 compared to CNY 0.0909 a year ago.